Company: PCRX
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001396814-25-000061
Chunk: 50

Company: Pacira BioSciences, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 50
---
-lease components, such as common area maintenance and other common operating expenses, along with executory costs such as insurance and real estate taxes. Total operating lease expense, net is as follows (in thousands):Three Months EndedMarch 31,20252024Fixed lease costs$3,302 $3,497 Variable lease costs539 494 Sublease income(57)(131)Total$3,784 $3,860 Supplemental cash flow information related to operating leases is as follows (in thousands):Three Months EndedMarch 31,20252024Cash paid for operating lease liabilities, net of lease incentives$3,262 $3,219 Right-of-use assets recorded in exchange for lease obligations$1,875 $— The Company has elected to net the amortization of the right-of-use asset and the reduction of the lease liability principal in other liabilities in the condensed consolidated statements of cash flows.The Company has measured its operating lease liabilities at an estimated discount rate at which it could borrow on a collateralized basis over the remaining term for each operating lease. The weighted average remaining lease terms and the weighted average discount rates are summarized as follows:March 31,20252024Weighted average remaining lease term5.01 years5.81 yearsWeighted average discount rate6.92 %7.01 %

Pacira BioSciences, Inc.  |  Q1 2025 Form 10-Q  |  Page 15

Maturities of the Company’s operating lease liabilities are as follows (in thousands):YearAggregate MinimumPayments Due2025 (remaining nine months)$9,567 202612,769 202712,316 202811,168 202911,056 Thereafter6,326    Total future lease payments63,202    Less: imputed interest(10,119)   Total operating lease liabilities$53,083 

NOTE 8—GOODWILL AND INTANGIBLE ASSETS

GoodwillThe Company’s goodwill arose from the GQ Bio Acquisition in February 2025. The change in the carrying value of the Company’s goodwill is summarized as follows (in thousands):Carrying ValueBalance at December 31, 2023$163,243 Goodwill impairment(163,243)Balance at December 31, 2024— Goodwill arising from the GQ Bio Acquisition20,763 Foreign currency adjustments757 Balance at March 31, 2025$21,